Is anemia associated with bone mineral density in chronic obstructive pulmonary disease?
Anemia is frequently present in patients with COPD and there is evidence that it is associated with lower whole body bone mineral density.
These data emphasize that higher dosages of thiazolidinediones are required for the treatment of arthritis than for restoring insulin sensitivity but that thiazolidinediones prevent inflammatory bone loss despite exposing animals to increased fatness possibly resulting from excessive activation of PPAR-gamma.